DALLAS, June 16, 2010 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces an investment report featuring Molecular Insight Pharmaceuticals Inc. (Nasdaq:MIPI). The report includes financial...
CALGARY, Alberta, April 20, 2010 (GLOBE NEWSWIRE) -- Emerging Stock Report, a leading provider of sector specific independent investment research, today initiated coverage on Molecular Insight...
DALLAS, April 15, 2010 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring Molecular Insight Pharmaceuticals Inc. (Nasdaq:MIPI). The report includes financial...
DALLAS, Feb. 22, 2010 (GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring biotech company Molecular Insight Pharmaceuticals Inc. (Nasdaq:MIPI). The report includes...
CALGARY, Alberta, Feb. 19, 2010 (GLOBE NEWSWIRE) -- Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on Molecular Insight...
DALLAS, June 19 /PRNewswire/ -- Investment opinion and research company InvestorSoup.com announces the availability of free, detailed stock alerts on active stocks in today's news. Each stock...
Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that David S. Barlow has resigned from the Board of Directors, effective December 30, 2008, citing...
Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today the publication of a preclinical study describing the synthesis and initial evaluation of two series of...
Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that results from a recently completed Phase 2 clinical study (BP-23) suggest that Zemiva, when combined...
Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced today that John W. Babich, Ph.D., Interim Chairman and Chief Executive Officer of Molecular Insight...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales